Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORA64 (SNORA64) is a non-coding RNA molecule classified as an H/ACA box snoRNA. Its primary function is to guide the pseudouridylation of uridine residues in ribosomal RNA, a critical step in ribosome biogenesis and RNA processing within the nucleolus. It does not encode a protein and is not currently considered a therapeutic target in the conventional sense, as it plays an indirect but essential role in cell biology and gene expression regulation[1]. ENSG00000202517 (SNORA64) is a small nucleolar RNA involved in RNA modification, not a protein or therapeutic target[1]. If you are seeking targets for drug discovery or therapeutic intervention, this would not be appropriate unless you are specifically interested in non-coding RNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA64 (SNORA64).